triggered by oxidative stress and associated with blood pressure elevation. 9, 12 It was proposed by several investigators that enhanced adaptive immunity arising from genetic predisposition and leading to vascular inflammation as a consequence of reduced immunosuppressant function of TREGs may play a role as well in hypertension. 9 However, the mechanisms implicating immune response in hypertension are still, in part, elusive. 3 In addition, no data are presently available concerning the role of T-lymphocyte subpopulations in the onset of microvascular damage in humans. The evaluation of microvascular structure in humans may be performed by locally invasive but highly accurate and specific approaches, such as wire or pressure micromyograpy, through the measurement of the media to lumen ratio (M/L) of subcutaneous small resistance arteries dissected from tissue biopsies, 13 a parameter with a relevant prognostic meaning. 13 Recently, noninvasive approaches were proposed for the evaluation of microvascular structure, including the measurement of the wall to lumen ratio (W/L) of retinal arterioles by scanning laser Doppler flowmetry, or capillaroscopic/videmicroscopic measurement of capillary density. 13 Therefore, the aim of our study was to evaluate possible relationships between circulating lymphocyte subtypes and microvascular damage, in a population of patients undergoing elective surgery.
PATIENTS AND METHODS
We have investigated 36 subjects and patients admitted to the Surgical Department of our hospital for indication to standard abdominal surgery, with no signs of systemic inflammation. In 15 cases, an elective cholecystectomy was performed, in 6 cases indication for surgery was an incidentaloma of the adrenals (no evidence of hormonal secretion), in 15 cases an intervention for inguinal, crural, or incisional hernia was performed. Twenty-four of them were normotensive and 12 hypertensive, according to the European Society of Hypertension/European Society of Cardiology guidelines 2007. 14 Ten out of 12 hypertensive patients were on treatment with antihypertensive drugs. Blood pressure was recorded by standard sphygmomanometric approach (3 measurements in lying position, 5 minutes apart) the day before surgical intervention. No washout of antihypertensive treatment was possible; therefore, blood pressure values recorded were those on treatment in 10 out of 12 cases. Antihypertensive drugs used included diuretics in 3 patients, angiotensin converting enzyme inhibitors in 3 patients, calcium channel blockers in 2 patients, angiotensin receptor blockers in 6 patients, β-blockers in 3 patients, and α 1 -blockers in 1 patient. Additional treatments included antiplatelet drugs in 21% and statins in 33% of the patients. The duration of previous antihypertensive treatment was, on average, of 4.3 years, and was slightly longer in patients in angiotensin converting enzyme inhibitors than in those assuming the remaining classes of drugs (5.5 years vs. 3.6 years). Duration of hypertension was estimated approximately 5.8 years.
No patients had diabetes mellitus, as well as clinical or laboratory signs of liver disease or obstructive sleep apnea syndrome.
The protocol of the study was approved by the ethics committee of our institution (Medical School, University of Brescia), and written informed consent was obtained from each participant. The procedures followed were in accordance with institutional guidelines.
Micromyography
All subjects were submitted to a biopsy of subcutaneous fat from the anterior abdominal region. The biopsy of the abdominal subcutaneous fat was taken during the surgical procedure. Surgery was never performed in patients with sign of systemic inflammation. Small arteries (about 100-280 µm of average diameter in relaxed conditions, 2 mm long) were dissected from the subcutaneous fat of the biopsies and mounted as a ring preparation on an isometric myograph (410 A, Danish Myo Technology, Aarhus, Denmark), by threading onto 2 stainless steel wires (40 µm diameter). After equilibration, the micromyograph was transferred to the stage of a light microscope with immersion lens. The vessel was stretched slightly (wall tension about. 0.1 N/m), and structural characteristics of the vessels were evaluated. The following parameters were directly measured or calculated: wall thickness, media thickness, internal diameter, tunica media to internal diameter ratio (M/L), media cross-sectional area. Details about the micromyographic technique of evaluation of small artery morphology were previously reported. [15] [16] [17] [18] The average values obtained from 2 vessels in each experiment were considered.
Evaluation of retinal arteriolar morphology
All subjects underwent an evaluation of the retinal arteriolar morphology 3-4 days after surgical intervention. W/L of retinal arterioles was assessed using scanning laser Doppler flowmetry at 670 nm (Heidelberg Retina Flowmeter, Heidelberg Engineering, Heidelberg, Germany), an established and validate method to investigate retinal perfusion. 13, [19] [20] [21] Briefly, an arteriole with a size between 80 and 140 µm of the superficial retinal layer in a retinal sample of 2.56 × 0.64 × 0.30 mm was scanned within 2 seconds, at a resolution of 256 points × 64 lines × 128 lines. Measurements were performed in the juxtapapillary area of the right eye, 2-3 mm temporal superior to the optic nerve; the mean from 3 measurements was taken. 19 Only arterioles that could unambiguously be discriminated and clearly be identified on the temporal superior side of the optic nerve were selected. Images of arterioles without sharp contrast to the retina or with crossing and overlapping of venules, curved arterioles, or arterioles with more than one bifurcation on the image and images with more than 4 eye movements were excluded. The examination was performed without mydriasis, in sitting position after 20 minutes of rest, at room temperature and daylight conditions between 8 am and 2 pm, but before lunch. Analyses of diameters were performed offline with automatic full-field perfusion imaging analysis program (Nirox Optoelectronics, Brescia, Italy). Outer arteriole diameter was measured in reflection images, and lumen diameter was measured in perfusion images. [19] [20] [21] W/L was calculated using the formula (arteriole diameter − lumen diameter)/ lumen diameter. [19] [20] [21] Reliability analysis of the W/L pointed out a good reproducibility of the scanning laser Doppler flowmetry measurement, with an intraobserver coefficient of variation around 8-9% and intraobserver coefficient of variation around 9-10%. 21, 22 Evaluation of capillary density Skin capillary density was assessed by capillaroscopy before and after venous congestion, as described elsewhere. [23] [24] [25] Briefly, after a period of rest in sitting position in a quiet and temperature-controlled room (21-22 °C), capillaries from nailfold and the dorsum of the fourth finger of the nondominant hand were visualized by using an epi-illuminated microscope containing a 100 W mercury vapour lamp light source, and pictures (final magnification of 200) were obtained by videomicroscopy (Videocap 3.0 D1 200, DS Medica, Milano, Italy) in baseline conditions (baseline capillary density) and after venous congestion (total capillary density), in order to visualize functionally excluded capillaries. Venous congestion was induced by inflating at to 60 mm Hg for 2 minutes a miniature blood pressure cuff applied to the base of the fourth finger of the nondominant hand. [23] [24] [25] Images (final magnification of 200) were also obtained before and after venous congestion at the distal third forearm on the sagittal line by using a traditional pressure cuff. Capillary density was defined as the number of capillaries per square millimeter of the microscopic field and was counted by hand. The first row of the nailfold capillaries was considered. Capillary density was determined by 2 independent operators and findings were averaged.
Evaluation of circulating CD4 + T-lymphocyte phenotype, Cytokine production by CD4 + T cells after in vitro activation, and TREG lymphocyte evaluation in small resistance arteries by methylation PCR analysis Circulating lymphocytes subpopulations were evaluated by flow cytometry, while TREG lymphocytes content in the wall of subcutaneous small resistance arteries was evaluated by methylation PCR analysis. Due to space limitations, detailed description of the methodology employed for such evaluations is reported in Supplemental Material.
Statistical analysis. All data are expressed as mean + SD. Differences between groups were evaluated by Student's unpaired t-test. Distribution of categorical variables between groups was evaluated by χ-square test. Relationships between variables were assessed by calculation of Pearson's correlation. All parameters were normally distributed. Since this may be considered a hypothesis-generating study, no correction for multiple comparison was performed. A value of P <0.05 was considered statistically significant. All analyses were carried out with SPSS software (version 13.0, SPSS, Chicago, IL).
RESULTS
Demographic characteristics of the population investigated in the study are reported in Table 1 .
Hypertensive patients were older and had a calculated creatinine clearance (Modification of Diet in Renal Disease (MDRD) Study equation formula) lower than normotensive controls. Serum creatinine was within normal limits in more than 90% of subjects and patients. No difference between groups was present in indications to surgery.
Microvascular structure and circulating T-lymphocytes
Data about morphology of microvessels and circulating CD4 + lymphocytes in the whole population, as well as in normotensive subjects and in hypertensive patients are reported in Tables 2 and 3. No significant difference in morphological parameters investigated was observed between hypertensive patients and normotensive subjects, both in retinal arterioles and in subcutaneous small resistance arteries (Table 3 ). Basal and total capillary density were similar in the different locations explored: nailfold and dorsum of the fourth finger of the nondominant hand and anterior surface of the nondominant forearm (Table 3) ; however, the difference between basal and total capillary density, both calculated as delta gain or % of capillary recruitment, was smaller in hypertensive patients than in normotensive subjects ( Table 3) .
The percentage and absolute number of circulating CD4 + CD28 − T-cells producing γ-IFN after in vitro activation were higher in hypertensive patients than in normotensive subjects ( Table 2 ). It might be hypothesized that the number of CD4 + CD28 − IFN-γ producing T-cells might increase with age. However, in our experience, a similar nonstatistically trend was observed only in normotensive individuals (r: 0.25; P > 0.05), whereas, on the contrary to what expected, in hypertensive individuals, a negative correlation was observed (r: −0.58; P < 0.05), clearly indicating that the differences between the 2 groups were not accounted for by age differences.
No other difference of circulating T-lymphocytes was observed between the 2 groups.
Relationships between circulating T-lymphocytes and microvascular structure A significant inverse correlation was observed between total TREGs and M/L ratio of subcutaneous small resistance arteries, while a direct correlation was observed between Th17 lymphocytes and M/L ratio of subcutaneous small resistance arteries (Table 4, Figure 1) . A significant inverse correlation was observed between total TREGs (RTE and naïve) and W/L ratio of retinal arterioles (Table 4 , Figure 2 ).
Total capillary density in the dorsum of the finger was significantly correlated with TREG effector memory cell circulating lymphocytes (Table 4, Figure 3) .
Finally, significant direct correlations were observed between Th2 lymphocytes subpopulation, evaluated either after 5 hours of activation (Table 4) or after 5 days of activation (see Supplemental Material) and basal or total capillary density on the different sites examined.
No statistically significant correlation between clinic systolic or diastolic blood pressure and lymphocyte subpopulations were observed.
We also specifically evaluated whether if the balance Th1/ TREGa or Th17/TREGs could be associated to an increase of blood pressure or to loss of capillary recruitment. However, no significant correlation was detected, either with blood pressure values or with capillary density or recruitment.
Relationship between TREG lymphocytes in small resistance arteries and microvascular structure and C-reactive protein A significant positive correlation was detected between TREG lymphocytes in small resistance arteries (at least as evaluated as FoxP3 unmethylated DNA fraction), and basal (0.48, r 2 = 0.23, P < 0.05), total (0.57, r 2 = 0.32, P < 0.05) and delta gain (0.53, r 2 = 0.28, P < 0.05) capillary density in the forearm, whereas no correlations were observed with small resistance artery M/L and retinal arteriole W/L.
In addition, a significant inverse correlation was detected between TREGs in subcutaneous small vessels and C-reactive protein (−0.45, r 2 = 0.20, P < 0.05).
DISCUSSION
Our study for the first time has shown that some lymphocyte subpopulations may be related to microvascular remodeling in humans, confirming previous animal data that provided the theoretical bases for our investigation.
It generally accepted that inflammation can increase the proliferation of smooth muscle cells and participates in vascular remodeling. 8 Infiltration of immune cells in various organs such as blood vessels, kidney, and perivascular adipose tissue is an important component of the inflammatory mechanisms leading to cardiovascular damage and hypertension. 3 An increasing number of studies have addressed the role of immunity in cardiovascular disease, revealing a new paradigm that includes the active participation of macrophages and immune-competent cells (particularly different subsets of lymphocytes) in the mechanisms associated with the pathophysiology of hypertension. Therefore, the importance of different components of the immune system, including innate immunity (e.g., macrophages) and adaptive immunity (T-effector lymphocytes and T-regulatory lymphocytes), in the development of hypertension has been underlined. 3 How activation of immunity is triggered remains unknown, but neoantigens could be generated by elevated blood pressure through damage-associated molecular pattern receptors or other mechanisms. 7 Once activated, Th1 cells may contribute to blood pressure elevation by affecting the kidney and the vascular remodeling of blood vessels directly via the effects of the cytokines produced or through their effects on perivascular fat. On the contrary, TREG cells might protect from blood pressure elevation by acting upon similar targets. 7 Viel et al. 10 hypothesized that adaptive immunity may be enhanced as result of a genetic predisposition with loci on chromosome 2, which bears many proinflammatory genes, in hypertensive models such as the Dahl salt-sensitive rat, which exhibits an activated endothelin system. The presence of the Brown Norway chromosome 2 on the Dahl salt-sensitive background in the consomic rat (SSBN2) was associated with upregulation of TREG markers and activity, Foxp3 transcription factor expression, and production of IL-10 and transforming growth factor-β. 10 Increased populations of T-lymphocytes and TREG cells in blood and spleen were associated with increased blood pressure values and vascular inflammation. 10 The vasculature of hypertensive rats revealed dysfunctional TREG cells that express low levels of Foxp3b and did not produce immunosuppressive mediators (transforming growth factor-β and IL-10), thus leading to upregulation of inflammatory responses. 10 Abbreviations: Abs number: absolute number; TREG RTE, recent thymus emigrant cells; TREG Naïve, no previous contact with antigens; TREG CM, T central memory cells; TREG EM, effector memory cell (highly antigen-experienced cells active in adaptive response); TREG TDEM, TDEM terminal differentiated effector memory (highly antigen-experienced cells that assume proapoptotic properties). *P < 0.05, **P < 0.01 vs. normotensive subjects.
This had also a structural counterpart, since in the aortas of Dahl salt-sensitive rats an increased wall thickness, an increased content in preproendothelin-1, and collagen content were detected. These alterations were partially attenuated in consomic rats. 10 These results support previous data regarding TREGs, suggesting that the immune system is involved in the development of cardiovascular disease 9 and that T-lymphocytes may influence blood pressure. 12 In fact, Guzik et al. 12 demonstrated that mice lacking T and B cells (RAG-1 −/− mice) compared with control C57BL/6 mice have blunted hypertension and do not develop abnormalities of vascular function or increased aortic wall thickness-wall area during angiotensin II infusion or desoxycorticosterone acetate-salt. Adoptive transfer of T, but not B, cells restored these abnormalities. 12 In another study, Barhoumi et al. 11 investigated male C57BL/6 mice, which were injected intravenously with TREGs or T-effector cells, and then infused or not with angiotensin II for 14 days. Angiotensin II increased systolic blood pressure and NADPH oxidase activity in the aorta and the heart, impaired acetylcholine-induced vasodilator responses compared with control, and increased vascular stiffness, mesenteric artery vascular cell adhesion molecule expression as well as aortic macrophage and T-cell infiltration. All these alterations were prevented by TREG but not by T-effector adoptive transfer. It seems therefore that TREGs suppress angiotensin II-mediated vascular injury in part through anti-inflammatory actions. These findings strongly support the idea that immune mechanisms modulate angiotensin II-induced blood pressure elevation, vascular oxidative stress, inflammation, and endothelial dysfunction.
Kassan et al. addressed the relationships between TREGs and vascular dysfunction in hypertension, suggesting that TREGs imbalance may be a major factor in vascular endothelial dysfunction, plaque rupture, and myocardial infarction. 26, 27 Available data about possible involvement of effector T-lymphocytes in humans are rather limited. 28, 29 Abbreviations: Abs number: absolute number; M/L, media to lumen ratio; TREG RTE, recent thymus emigrant cells; TREG Naïve, no previous contact with antigens; TREG CM, T central memory cells; TREG EM, effector memory cell (highly antigen-experienced cells active in adaptive response); TREG TDEM, TDEM terminal differentiated effector memory (highly antigen-experienced cells that assume proapoptotic properties); W/L, wall to lumen ratio.
However, in human hypertension, with aging, effector lymphocytes may become senescent, and lose some of their CD28 leading to blunting of the CD28:CD80/86 co-stimulation axis, increased surface adhesion molecules and cytolytic enzyme expression, and enhanced cytotoxicity. 30 In our study, an increase of CD4 + CD28 − IFN-γ+ Th1 circulating lymphocytes was observed in hypertensive patients, compared with normotensive subjects. This population corresponds to senescent lymphocytes and was previously demonstrated to be increased in some pathological conditions, including patients with aortic aneurisms, 31 unstable angina, 32 and early atherosclerotic damage. 33 Therefore, T cells might contribute to human hypertension 34 as suggested by animal studies and may also play a role in the development/maintenance of microvascular structural alterations. 35 As mentioned, our study provides a demonstration that some circulating T-lymphocyte subpopulations may, to some extent, influence microvascular structure and capillary density in humans. In particular, TREG lymphocytes seem to be protective, since an inverse correlation was observed with M/L of subcutaneous small resistance arteries and W/L or retinal arteriole, evaluated noninvasively, and these results are in agreement to what previously observed in animals. 36 In addition, we observed that Th2 lymphocyte subpopulations are directly related with basal or total capillary density, thus suggesting a protective or proangiogenetic role of these lymphocytes.
The role of Th2 lymphocytes in terms of effects on microvascular structure or angiogenesis is poorly understood, and in general both a protective and a detrimental role of this T-lymphocyte subpopulation could be expected on the bases of the available data. 37 However, some data suggest that Th1 and Th2 lymphocytes seem to be modulated in opposite directions; therefore, an increase in Th1 lymphocytes might be associated to a decrease in Th2 lymphocytes. 38, 39 In addition Th1/Th2 balance is crucial to the chronic inflammation in initiation and development hypertension and atherosclerosis. 39 Since there is hardly any doubt that Th1 lymphocytes may exert a detrimental role in terms of elaboration of reactive oxygen species, production of vasoactive cytokines and promoting inflammation, 28,29 a protective role of Th2 lymphocytes, even on the microcirculation is theoretically possible.
Finally, a correlation, although not a close one, was observed between Th17 circulating lymphocytes and M/L ratio of subcutaneous small resistance arteries, thus confirming previous data about a possible role of this specific subtype of T-effector cells in hypertension and organ damage. 3, 40 Indeed, IL-17 has been demonstrated to contribute to a vascular inflammatory response and it represents an important mediator in angiotensin II-induced hypertension as well as in other model of experimental hypertension. 3, 40 Moreover, several evidences have demonstrated an increase in Th17 cells in patients with acute coronary syndrome and unstable carotid atherosclerotic plaques with a significant functional imbalance of Th17/TREG lymphocytes. 41 Similarly, an increase of the Th17 subtype was observed also in patients with type 2 diabetes mellitus, suggesting that Th17 subset may particularly take part in the pathogenesis of cardiovascular and metabolic diseases. 42 
Limitation of the study
Our study has the limitations inherent to many human studies adopting locally invasive procedures (micromyography). The number of the subjects and patients enrolled is relatively limited, the population enrolled partially heterogeneous (treated and nontreated patients) and the correlations observed were relatively weak.
In particular, our hypertensive patients had well-controlled blood pressure values, and therefore, no difference in indices of microvascular structural alterations was observed compared with normotensive controls, as previously observed in other studies, 19 in which no differences in W/L of retinal arterioles were observed between treated hypertensive and normotensive controls.
This may have reduced the possibility to detect more close correlations between indices of small artery structure, whose range was narrowed by the lack of subjects/patients with severely altered vessels. In addition, the majority of T-lymphocyte subpopulations were evaluated in the circulation and not in the vessel wall, therefore reasonably no closer correlations should be expected, due to the many, unavoidable confounders. Glomerular filtration rate was slightly different between hypertensives and normotensives, but within normal limits in the majority of our population. Age represents a factor that may affect vascular structure per se; however, there were no significant correlations between glomerular filtration rate or age, and M/L, W/L or lymphocytes subpopulations, both in the overall population and in our subgroups. Also, previous antihypertensive treatment may have represented a confounding factor. It is not presently known whether antihypertensive treatment might affect TREGs or other lymphocyte subpopulations, although specific effects of some antihypertensive dug classes, particularly those with ancillary antioxidant properties cannot be excluded; it is however well known that some antihypertensive drugs are more effective that others in terms of regression of microvascular structural alterations. 13 In addition, only clinic blood pressure values were available in our population.
In the analysis of cytokine producing T-cells after in vitro stimulation, CD3+CD8-T-cells were considered as T CD4 + . The contribution of double negative CD4 − CD8 − T-cells which can also produce proinflammatory cytokines such as IL-17 and interferon-γ cannot therefore be excluded.
Detection of FoxP3 in small biopsies is not optimal and can be affected by number of factors; therefore results obtained should be taken with some caution, although our methodological approach is generally considered specific enough for TREG lymphocyte subpopulations (see Supplemental Material). Finally, being a hypothesis-generating study, we did not make corrections for multiple comparisons. This might have exposed to the risk of generating false positive results.
Clinical perspectives
As mentioned, subsets of T-lymphocytes have been implicated in the pathogenesis of hypertension and vascular remodeling. This is an area of active research and rapid development in cardiovascular and renal disease. 9 It was already shown that immunosuppressant drugs such as mycophenolate mofetil may reduce blood pressure values and protect from renal damages Dahl salt-sensitive rats, 43 as well as mice infused with angiotensin II. 44, 45 In another study, 46 partial depletion of TREGs with an anti-CD25 monoclonal antibody potentiated kidney damage induced by ischemia-reperfusion injury. Interestingly enough, in immune-suppressed patients with human immune deficiency virus-associated disease, although cardiovascular disease may occur in part as a result of side effects of antiviral agents used in the treatment of the disease, there is no excess prevalence of hypertension that has been noted. 36 Since an obligatory role even for B cells in the development of angiotensin II-dependent hypertension was demonstrated, B cell-targeted therapies currently used for autoimmune diseases may hold promise as future treatments for hypertension. 47 Finally, very recent data suggested a role for the angiogenic factor placental growth factor (PIGF) as a mediator of a neuroimmune interaction in the spleen that allows the onset of hypertension, 48 also in this case opening therapeutic perspectives.
In conclusion, adaptive immune systems may contribute to the pathogenesis of cardiovascular disease and vascular remodeling probably through inflammation and oxidative stress. TREG lymphocytes, which elicit an anti-inflammatory activity, may be crucial for blood pressure elevation and organ damage development, at least in experimental models. Moreover, Th2 lymphocytes (producing IL-4 and -5) seem to blunt inflammation.
Our data suggest that TREG and Th2 lymphocytes may be protective against microvascular damage, probably because of their anti-inflammatory and antioxidant properties confirming an involvement of adaptive immune system on microvascular remodeling and rarefaction.
Although this evidence in humans could be relevant, however, no direct causative association can be deducted in human hypertension from our data.
Prospectively, these new data implicating T-lymphocytes could eventually allow discovery of new therapeutic targets that may improve outcomes in hypertension and cardiovascular or renal disease in humans. 7, 9 On the other hand, like in other cardiovascular disease, circulating CD4 + CD28 − γ-IFNproducing T-cells were raised in hypertensive patients. In patients with rheumatoid arthritis treated with abatacept, a CD28 costimulation blocker, we observed a reduction of the number of circulating CD4 + CD28 − T cells, 49 of CD4 + Th17, and of CD4 + CD28 − γ-IFN-producing T cells. 50 These findings seem to be promising as far as the possibility to target these T-cell populations.
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